Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Human papillomavirus, cancer and vaccination.

Heard I.

Curr Opin HIV AIDS. 2011 Jul;6(4):297-302. doi: 10.1097/COH.0b013e328347335d. Review.

PMID:
21519247
2.

Human papillomavirus, human immunodeficiency virus and immunosuppression.

Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J.

Vaccine. 2012 Nov 20;30 Suppl 5:F168-74. doi: 10.1016/j.vaccine.2012.06.045. Review.

PMID:
23199960
3.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
4.

Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.

PMID:
20719211
5.

Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.

Poljak M.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Review.

6.

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.

Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.

Vaccine. 2010 Nov 29;28(51):8065-72. doi: 10.1016/j.vaccine.2010.10.017. Epub 2010 Nov 16. Review.

PMID:
20971114
7.

Quadrivalent human papillomavirus vaccine.

Barr E, Tamms G.

Clin Infect Dis. 2007 Sep 1;45(5):609-7. Epub 2007 Jul 25. Review.

PMID:
17682997
8.

Prevention of cervical cancer in women with HIV.

Heard I.

Curr Opin HIV AIDS. 2009 Jan;4(1):68-73. doi: 10.1097/COH.0b013e328319bcbe. Review.

PMID:
19339941
9.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
10.

Human papillomavirus vaccines: an update for gynecologists.

Ault KA.

Clin Obstet Gynecol. 2008 Sep;51(3):527-32. doi: 10.1097/GRF.0b013e31818092df. Review.

PMID:
18677145
11.

Human papillomavirus vaccines and anal carcinoma.

Franceschi S, De Vuyst H.

Curr Opin HIV AIDS. 2009 Jan;4(1):57-63. doi: 10.1097/COH.0b013e32831b9c81. Review.

PMID:
19339940
12.

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.

PLoS Med. 2006 May;3(5):e138. Epub 2006 Apr 4.

13.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
14.

Introduction of human papillomavirus vaccination in Nordic countries.

Sander BB, Rebolj M, Valentiner-Branth P, Lynge E.

Vaccine. 2012 Feb 14;30(8):1425-33. doi: 10.1016/j.vaccine.2011.11.097. Epub 2011 Dec 7. Review.

PMID:
22154773
15.

Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.

Schwarz TF.

Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Review.

PMID:
20024678
16.

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR.

Int J Gynecol Cancer. 2009 Oct;19(7):1166-76. doi: 10.1111/IGC.0b013e3181a3d100. Review.

PMID:
19823051
17.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
18.

An overview on the implementation of HPV vaccination in Europe.

Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:128-35. Epub 2011 Jan 1. Review.

PMID:
21245659
19.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
20.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Epub 2007 Jan 18. Review.

PMID:
17292517

Supplemental Content

Support Center